Clinical Trial: Efficacy and Safety of Depemokimab Monotherapy Without Concomitant Use of Intranasal Corticosteroids (INCS) in Japanese Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07701967) titled 'Efficacy and Safety of Depemokimab Monotherapy Without Concomitant Use of Intranasal Corticosteroids (INCS) in Japanese Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)' on July 09.

Brief Summary: This study will evaluate the efficacy and safety of depemokimab (GSK3511294) without concomitant use of Intranasal corticosteroids (INCS) in participants with Chronic rhinosinusitis with nasal polyps (CRSwNP).

Study Start Date: July 20

Study Type: INTERVENTIONAL

Condition: Nasal Polyps

Intervention: BIOLOGICAL: Depemokimab

Participants will receive depemokimab.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Gla...